CAMBRIDGE, Massachusetts and TORONTO, Ontario, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (PMN), a biotechnology company focused on the generation and development of therapeutics ...
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...
JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody ...
Featuring Keynote "Reuniting the Mind with the Heart" ATLANTA, Feb. 16, 2026 /PRNewswire/ -- The Atlanta Neuroscience Institute and Foundation proudly announce the 2026 World Neuroscience Day ...
Neurodegenerative Diseases: New Insights and Therapeutic Opportunities to advance discussion about therapies for Alzheimer's disease among world's leading researchers In the poster, "Selective ...
The annual Society for Neuroscience (SfN) conference is currently underway in Chicago. Thousands of neuroscientists have gathered here to discuss the latest topics in neuroscience research. They’re ...
BUFFALO, N.Y. – Cocaine and brain function. Susceptibility to alcoholism. Smoking and schizophrenia. Marijuana and stress. Dozens of research scientists from across New York State will discuss these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results